Dendritic Cells in Cancer Immunotherapy Clinical Trials: Are We Making Progress?

Por Butterfield, Lisa H.
Publicado em 2013

Cancer vaccines

Por Butterfield, Lisa H
Publicado no BMJ (2015)

Lessons learned from cancer vaccine trials and target antigen choice

Por Butterfield, Lisa H.
Publicado no Cancer Immunol Immunother (2016)

New approaches to the development of adenoviral dendritic cell vaccines in melanoma

Por Butterfield, Lisa H, Vujanovic, Lazar
Publicado em 2010

Immunotherapy of hepatocellular carcinoma: Unique challenges and clinical opportunities

Por Pardee, Angela D., Butterfield, Lisa H.
Publicado em 2012

Dendritic Cell Control of Immune Responses

Por Morel, Penelope A., Butterfield, Lisa H.
Publicado no Front Immunol (2015)

Alpha fetoprotein directly induces a unique pro-inflammatory, IL-2 hyperresponsive phenotype in human natural killer cells

Por Vujanovic, Lazar, Stahl, Elizabeth, Butterfield, Lisa H
Publicado no J Immunother Cancer (2014)

Dendritic Cell-Based Vaccines Positively Impact Natural Killer and Regulatory T Cells in Hepatocellular Carcinoma Patients

Por Bray, Sarah M., Vujanovic, Lazar, Butterfield, Lisa H.
Publicado em 2011

Cellular immunity induced by a recombinant adenovirus- human dendritic cell vaccine for melanoma

Por Naveh, Hadas Prag, Vujanovic, Lazar, Butterfield, Lisa H
Publicado em 2013

Tumor-derived alpha-fetoprotein impairs the differentiation and T cell stimulatory activity of human dendritic cells

Por Pardee, Angela D., Shi, Jian, Butterfield, Lisa H.
Publicado no J Immunol (2014)

Tumor-derived alpha-fetoprotein impairs the differentiation and T cell stimulatory activity of human dendritic cells

Por Pardee, Angela D, Shi, Jian, Butterfield, Lisa H
Publicado no J Immunother Cancer (2014)

Multiplex serum biomarker assessments: technical and biostatistical issues

Por Butterfield, Lisa H, Potter, Douglas M, Kirkwood, John M
Publicado em 2011

Transduction of human dendritic cells with adenovirus encoding anti-PD-1 reduces PD-1 expression on co-cultured T cells

Por Patricia, Santos, Alexander, Etheridge, Gambotto, Andrea, Butterfield, Lisa H
Publicado no J Immunother Cancer (2014)

Melanoma-associated Leukoderma – Immunology in Black and White?

Por Naveh, Hadas Prag, Rao, Uma N. M, Butterfield, Lisa H.
Publicado em 2013

Alpha fetoprotein DNA prime and adenovirus boost immunization of two hepatocellular cancer patients

Por Butterfield, Lisa H, Economou, James S, Gamblin, T Clark, Geller, David A
Publicado em 2014

AFP-specific CD4(+) Helper T-cell Responses in Healthy Donors and HCC Patients

Por Evdokimova, Viktoria N., Liu, Yang, Potter, Douglas M., Butterfield, Lisa H.
Publicado em 2007

Ependymomas: Development of Immunotherapeutic Strategies

Por Pollack, Ian F., Jakacki, Regina I., Butterfield, Lisa H, Okada, Hideho
Publicado em 2013

Tumor-derived alpha-fetoprotein (tAFP) causes immune and metabolic dysfunction in monocyte-derived dendritic cells

Por Santos, Patricia M, Pardee, Angela, Delgoffe, Greg M, Butterfield, Lisa H
Publicado no J Immunother Cancer (2015)

Adenovirus-engineered human dendritic cells induce natural killer cell chemotaxis via CXCL8/IL-8 and CXCL10/IP-10

Por Vujanovic, Lazar, Ballard, Wenners, Thorne, Stephen H., Vujanovic, Nikola L., Butterfield, Lisa H.
Publicado em 2012

Molecular mimicry of MAGE-A6 and Mycoplasma penetrans HF-2 epitopes in the induction of antitumor CD8(+) T-cell responses

Por Vujanovic, Lazar, Shi, Jian, Kirkwood, John M, Storkus, Walter J, Butterfield, Lisa H
Publicado no Oncoimmunology (2014)